Generate Biomedicines, Inc. (GENB) Insider Trading
0 insider purchases in the last 7 days
No open market insider purchases at Generate Biomedicines, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track GENB on your watchlist.
Start for FreeAbout Generate Biomedicines, Inc. Insider Trading
5 insiders at Generate Biomedicines, Inc. (GENB) have purchased stock in the past 90 days, totaling $50.3M across 7 transactions (3,148,300 shares).
The most recent purchase was by CEO Nally Michael on March 4, 2026 — a $240K buy of 20,000 shares at $12.00, bringing his total holdings to 572,707 shares.
Insiders who purchased: AFEYAN NOUBAR (Director, 2 buys totaling $50.0M); Nally Michael (CEO, 1 buy totaling $240K); Mendillo Jane L (Director, 1 buy totaling $24K); Silvers Jason (CFO, 2 buys totaling $24K); Grous Beth (Chief People Officer, 1 buy totaling $5K).
This insider buying is notable given that GENB had no recorded open market purchases in the nine months before that.
With 5 different insiders buying in the same 90-day window, this qualifies as cluster buying at GENB — a pattern that research suggests can signal conviction among management.
Track GENB insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.